Early detection in a mouse model of pancreatic cancer by imaging DNA damage response signalling

Early detection in a mouse model of pancreatic cancer by imaging DNA damage response signalling

<p><strong>Rationale:</strong> Despite its widespread use in oncology, the PET radiotracer 18F-FDG is ineffectivefor improving early detection of pancreatic ductal adenocarcinoma (PDAC). An alternative strategy for early detection of pancreatic cancer involves visualisation of high...

Full description

Bibliographic Details
Main Authors:	Cornelissen, B, Knight, J, Baguna Torres, J, Goldin, R, Mosley, M, Dias, G, Contreras Bravo, L, Kersemans, V, Allen, P, Mukherjee, S, Smart, S
Format:	Journal article
Published:	Society of Nuclear Medicine 2019

Similar Items

Early detection of pancreatic cancer in KPC mice by imaging DNA damage signalling
by: Knight, J, et al.
Published: (2018)

89Zr-anti-γH2AX-TAT but not 18F-FDG allows early monitoring of response to chemotherapy in a mouse model of pancreatic ductal adenocarcinoma
by: Knight, J, et al.
Published: (2017)

Imaging DNA damage repair in vivo following 177Lu-DOTATATE therapy
by: O'Neill, E, et al.
Published: (2019)

Imaging of claudin-4 in pancreatic ductal adenocarcinoma using a radiolabelled anti-claudin-4 monoclonal antibody
by: Torres, J, et al.
Published: (2017)

Radiolabeled cCPE peptides for SPECT imaging of claudin-4 overexpression in pancreatic cancer
by: Baguna-Torres, J, et al.
Published: (2020)

[18F]Olaparib: Precision radiolabelling of PARP inhibitors for in vivo imaging
by: Wilson, T, et al.
Published: (2018)

Dual-isotope imaging reveals inter-individual differences in passive uptake of radiolabelled antibodies in tumours
by: Knight, J, et al.
Published: (2018)

Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours
by: Knight, J, et al.
Published: (2019)

PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.
by: Knight, J, et al.
Published: (2015)

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
by: Cornelissen, B, et al.
Published: (2012)

Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical
by: Cornelissen, B, et al.
Published: (2012)

Subcutaneous tumor volume measurement in the awake, manually restrained mouse using MRI.
by: Kersemans, V, et al.
Published: (2013)

PET imaging of DNA damage using 89Zr-labelled anti-γH2AX-TAT immunoconjugates
by: Knight, J, et al.
Published: (2015)

Imaging DNA damage allows detection of preneoplasia in the BALB-neuT model of breast cancer.
by: Cornelissen, B, et al.
Published: (2014)

Tumor imaging using radiolabelled matrix metalloproteinase-activated anthrax proteins
by: Xavier, M, et al.
Published: (2019)

Imaging DNA damage response (DDR) during oncogenesis
by: Cornelissen, B, et al.
Published: (2013)

Claudin-4 SPECT imaging allows detection of aplastic lesions in a mouse model of breast cancer
by: Mosley, M, et al.
Published: (2015)

Imaging p53 in Pancreatic Ductal Adenocarcinoma (PDAC)
by: Koustoulidou, S, et al.
Published: (2016)

Imaging of pancreatic tumours in mice using radiolabelled anti-Claudin4 antibodies
by: Mosley, M, et al.
Published: (2016)

Imaging the DNA damage response with PET and SPECT
by: Knight, J, et al.
Published: (2017)

89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma
by: Knight, J, et al.
Published: (2016)

PET imaging of PARP expression using [18F]olaparib
by: Wilson, T, et al.
Published: (2018)

Micro-CT for anatomic referencing in PET and SPECT: radiation dose, biologic damage, and image quality.
by: Kersemans, V, et al.
Published: (2011)

Imaging DNA damage in vivo using gammaH2AX-targeted immunoconjugates.
by: Cornelissen, B, et al.
Published: (2011)

[18F]AZD2461, an insight on difference in PARP binding profiles for DNA damage response PET imaging
by: Guibbal, F, et al.
Published: (2020)

MR and CT compatible electrical heating system for mouse imaging
by: Gilchrist, S, et al.
Published: (2019)

Characterising In-111-anti-gamma H2AX-TAT in targeting the DNA damage signal associated with Wnt activated colorectal cancer
by: Konstantinou, M, et al.
Published: (2016)

89Zr-PET imaging of DNA double-strand breaks for the early monitoring of response following α- and β-particle radioimmunotherapy in a mouse model of pancreatic ductal adenocarcinoma
by: Poty, S, et al.
Published: (2020)

99mTc-duramycin imaging reveals variable tissue toxicity of cancer drugs
by: Sneddon, D, et al.
Published: (2018)

Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma
by: Chung Ying Chan, et al.
Published: (2022-10-01)

Manganese-free chow, a refined non-invasive solution to reduce gastrointestinal signal for T1-weighted MRI of the mouse abdomen
by: Kersemans, V, et al.
Published: (2019)

A carbon-fiber sheet resistor for MR-, CT-, SPECT-, and PET-compatible temperature maintenance in small animals
by: Kersemans, V, et al.
Published: (2019)

Reduced respiratory motion artefact in constant TR multi-slice MRI of the mouse
by: Kinchesh, P, et al.
Published: (2019)

In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.
by: Kersemans, V, et al.
Published: (2005)

Cleavage of Early Mouse Embryo with Damaged DNA
by: Vladimír Baran, et al.
Published: (2022-03-01)

DNA-PKcs-dependent signaling of DNA damage in Dictyostelium discoideum.
by: Hudson, J, et al.
Published: (2005)

Cell penetrating peptides for in vivo molecular imaging applications.
by: Kersemans, V, et al.
Published: (2008)

Immuno-imaging of ICAM-1 in tumours by SPECT
by: Mosley, M, et al.
Published: (2020)

DNA damage signaling and repair in Dictyostelium discoideum.
by: Hsu, D, et al.
Published: (2006)

DNA damage repair mutations in pancreatic cancer– prognostic or predictive?
by: Ya-Fei Hu, et al.
Published: (2023-10-01)